Literature DB >> 6259351

Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole.

C T Kennedy, H Valdimarsson, R J Hay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6259351      PMCID： PMC1438641          DOI： 10.1177/014107688107400213

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  14 in total

1.  Endocrine candidosis syndrome.

Authors:  J P Mackey
Journal:  Ir J Med Sci       Date:  1975-01       Impact factor: 1.568

2.  Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E.

Authors:  R E Van Scoy; H R Hill; R E Ritts; P G Quie
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

3.  Disseminated candidiasis in a previously healthy girl: implication of a leukocyte candidacidal defect.

Authors:  P J Staples; J Boujak; R G Douglas; J P Leddy
Journal:  Clin Immunol Immunopathol       Date:  1977-03

4.  Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis.

Authors:  R Snyderman; L C Altman; A Frankel; R M Blaese
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

5.  Immune abnormalities associated with chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; J M Higgs; R S Wells; M Yamamura; J R Hobbs; P J Holt
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

6.  Functions of phagocytic cells in chronic mucocutaneous candidiasis.

Authors:  J W Van Der Meer; P C Leijh; R Van Furth
Journal:  Br Med J       Date:  1978-01-21

Review 7.  Therapeutic uses of transfer factor.

Authors:  W H Hitzig; P J Grob
Journal:  Prog Clin Immunol       Date:  1974

8.  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors:  A Fischer; J J Ballet; C Griscelli
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  Participation of C3 in intracellular killing of Candida albicans.

Authors:  M Yamamura; H Valdimarsson
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.

Authors:  D Dixon; S Shadomy; H J Shadomy; A Espinel-Ingroff; T M Kerkering
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226
View more
  3 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 2.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.

Authors:  S Fanconi; R Seger; P Joller; C Issler; G Schär
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.